TickerFacts.

Sigyn Therapeutics, Inc. (SIGY): Operating Cash Flow

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$872.4K
Year ended 2024-12-31
-$936.4K
Trailing 12 months to 2025-09-30
2017-12-31: -$400.0K2018-12-31: -$286.1K2019-12-31: -$143.7K2020-12-31: -$829.8K2021-12-31: -$1.77M2022-12-31: -$1.83M2023-12-31: -$1.38M2024-12-31: -$872.4K-$872.4K
2017-12-31 Operating Cash Flow (USD) 2024-12-31
Period endedOperating Cash FlowChange YoYSource filing
2024-12-31-$872.4Kn/m2025-04-15, From 2024-01-01
2023-12-31-$1.38Mn/m2025-04-15, From 2023-01-01
2022-12-31-$1.83Mn/m2024-02-20, From 2022-01-01
2021-12-31-$1.77Mn/m2023-03-31, From 2021-01-01
2020-12-31-$829.8Kn/m2022-03-21, From 2020-01-01
2019-12-31-$143.7Kn/m2020-03-30, From 2019-01-01
2018-12-31-$286.1Kn/m2020-03-30, From 2018-01-01
2017-12-31-$400.0Kn/a2019-04-01, From 2017-01-01